Trial Search Results

Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection

To compare the positivity rate of the investigational assay to the currently approved QuantiFERON-TB Gold In-Tube assay.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

QIAGEN Gaithersburg, Inc

Stanford Investigator(s):


  • Device: CST001


Low Risk and Known Risk Cohorts

Inclusion Criteria:

   - Compensated and uncompensated members (current or future) of the Department of
   Veterans Affairs with no identified symptoms of active TB disease

   - Age greater than 18 years or less than 80 years.

Exclusion Criteria:

   - Currently taking therapy for active tuberculosis or latent TB infection for more than
   14 days.

Ages Eligible for Study

18 Years - 80 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Mark Holodniy, MD
Not Recruiting